Click to Share
 

Antibody Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12587889
By NanoTemper Technologies GmbH
Unique applications offer one-click assays for highest-quality data
12557019
By Biosceptre International Limited
Biosceptre announces today that Sir Gregory Winter, founder of Cambridge Antibody Technology, Domantis and a co-founder of Bicycle Therapeutics Limited has joined the Board as a non-executive Director.
12549860
By BioVision Inc
Trial size antibodies are convenient and economical solution for researchers to explore several targets for screening. BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs.
By ImmunoReagents, Inc.
RALEIGH, NC, USA –ImmunoReagents is proud to announce LigaTrap™ purification resins and kits. LigaTrap™ technology utilizes novel, patented ligands, designed for antibody purification.
12504014
By Creative Biolabs
Creative BIolabs is glad to release its technique—human antibody production from transgenic mice.
12353691
By Cambridge Healthtech Institute
Bringing Industry, Academia and Regulatory Authorities Together to Produce Safe and Efficacious Products for the Clinic and Beyond
By Cambridge Healthtech Institute
Delegates now have the option to choose from 9 moderated breakout discussion groups on immunogenicity facilitated by industry and academic experts.
12287331
By ImmunoChemistry Technologies
Conjugate stabilizers prolong the shelf-life of conjugated antibodies and other proteins, enhancing their utility in ELISA and Western applications.
By Cambridge Healthtech Institute
Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
12204119
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
12083466
By Visiongain
A new report by Visiongain shows that next-generation technologies will become a major driver for the antibody therapeutics market.
By Cambridge Healthtech Institute
CHI’s 4th Annual Cancer Biologics, February 13-15, 2013, San Francisco, CA
By Sedia Biosciences Corp.
Phase I funding of the competitive grant is to develop a novel commercial assay to measure host HIV antibody avidity ("binding ability"), an indicator of antibody maturation, which can be used to determine recent vs. long-term HIV-1 infections.
By tebu-bio
tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.
By China Research and Intelligence
Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.
By Adrienne O'Reilly
New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR.
By GTC Conference
David Woodward, Senior Director of Biological Sciences at Allergan and Barbara Wirostko, Chief Medical Officer at Altheos will give a joint featured presentation at the 4th Ocular Diseases and Drug Discovery Conference
11611730
By Insight Pharma Reports
Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 Report

All Press Releases

12587889
By NanoTemper Technologies GmbH
Unique applications offer one-click assays for highest-quality data
12557019
By Biosceptre International Limited
Biosceptre announces today that Sir Gregory Winter, founder of Cambridge Antibody Technology, Domantis and a co-founder of Bicycle Therapeutics Limited has joined the Board as a non-executive Director.
12549860
By BioVision Inc
Trial size antibodies are convenient and economical solution for researchers to explore several targets for screening. BioVision is releasing hundreds of best performing Trail size antibodies to meet all your early stage research needs.
By ImmunoReagents, Inc.
RALEIGH, NC, USA –ImmunoReagents is proud to announce LigaTrap™ purification resins and kits. LigaTrap™ technology utilizes novel, patented ligands, designed for antibody purification.
By DelveInsight Business Research
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015” to its portfolio.
12504014
By Creative Biolabs
Creative BIolabs is glad to release its technique—human antibody production from transgenic mice.
By Cambridge Healthtech Institute
Largest European Event for Biologics Returns to Lisbon from 2-6 November
By GeneTex
GeneTex offers an outstanding selection of antibodies to support hypoxia research.
By Visiongain
A new report by visiongain predicts that the world next-generation antibody therapies market will reach $2.3bn in 2015.
By GeneTex
GeneTex proudly offers a large selection of high-quality antibodies for cancer research, including well-validated TSG101 antibodies.
By GeneTex
GeneTex proudly offers a large selection of high-quality antibodies for stem cell and neuroscience research, including well-validated Vimentin antibodies.
By GeneTex
GeneTex is very proud to offer an outstanding mouse monoclonal antibody that detects γ-H2AX.
By GeneTex
GeneTex proudly offers a large selection of high-quality antibodies for stem cell and cancer research, including well-validated CD44 antibodies.
By GeneTex
GeneTex proudly offers a large selection of high-quality antibodies for stem cell research, including well-validated CD45 antibodies.
By GeneTex
Ki-67 is a nonhistone nuclear protein that is detectable in all active stages of the cell cycle, but not in resting cells.
By GeneTex
GeneTex is proud to offer an excellent selection of Oct4 and related antibodies to assist in your research!
By GeneTex
Colorectal cancer is the second leading cause of cancer-related death in the United States.
By GeneTex
Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer among men and continues to pose a major clinical challenge for diagnosis and treatment.
By GeneTex
GeneTex proudly offers excellent Notch1 antibodies to assist your neural systems research.
By GeneTex
GeneTex proudly offers an excellent selection of SOX2 and related antibodies to assist your embryonic stem cell research.
By GeneTex
Immunotherapeutic approaches to cancer treatment continue to generate great interest.
By GeneTex
GeneTex proudly offers an excellent selection of FIS1 and related antibodies to assist your mitochondrial research.
By GeneTex
GeneTex proudly offers excellent doublecortin antibodies to assist in your neuroscience research.
By GeneTex
GeneTex proudly offers an excellent Nanog antibody to assist your embryonic stem cell research.
By GeneTex
Push your research forward with Nestin! GeneTex proudly offers an excellent Nestin antibody to assist your neural systems research.
By GeneTex
Don’t run out of Runx2 antibody! GeneTex's Runx2 is well validated and ready to help accelerate your research!
By GeneTex
Cas9 antibody for ICC/IF, IP, WB - Mouse monoclonal antibody [7A9] to Cas9
By ImmunoReagents Inc.
RALEIGH, NC, USA – May 19, 2015 – U.S. Secretary of Commerce Penny Pritzker has presented ImmunoReagents with the President’s “E” Award for Exports at a ceremony in Washington, DC.
By GeneTex
TET1 antibody for ICC/IF, IHC, IHC-P, WB and ChIP Assay. N3C1 polyclonal.
By GeneTex
Immunotherapeutic approaches to cancer treatment continue to generate great interest. In an excellent Nature Reviews Cancer "Perspectives" discussion, Coulie et.al.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share